Doi:10.1016/S0040-4039(01)82583-1

Doi:10.1016/S0040-4039(00)91202-4

Doi:10.1111/j.1432-1033.1973.tb02771.x

Silyl modification of biologically active compounds. 10. Lipid type organosilicon derivatives of 8-hydroxyquinoline and n-(2-hydroxyethyl)-1,2,3,4- tetrahydro(sila, iso)quinolines

Doi:10.1007/s10593-005-0192-6

Partial hydrolysis of rhenium and osmium hexafluorides. An improved synthesis and characterization of rhenium oxide tetrafluoride

Doi:10.1021/ic50124a060

Design of new quinolin-2-one-pyrimidine hybrids as sphingosine kinases inhibitors

Doi:10.1016/j.bioorg.2019.103414

191531-86-9

6926-50-7

1369933-49-2

383905-99-5

20156-49-4

21124-66-3

15086-09-6

927423-16-3

12267-22-0

7501-91-9

13307-75-0

1322788-81-7

41202-77-1

1441057-15-3

642-99-9

108561-04-2

1448846-11-4

102713-35-9

65042-30-0

162611-86-1

98225-48-0

28172-18-1

7637-07-2

251441-52-8

15875-69-1

160954-34-7

18241-35-5

828-51-3

158139-98-1

117857-80-4

55289-06-0

497-30-3